Argenx
ARGX
#534
Rank
โ‚ฌ36.80 B
Marketcap
601,86ย โ‚ฌ
Share price
-0.35%
Change (1 day)
87.05%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚ฌ0.51 Billion

According to Argenx 's latest financial reports the company's total liabilities are โ‚ฌ0.51 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Argenx - Total liabilities on balance sheet (from 2013 to 2020)

Total liabilities by year

Year Total liabilities Change
2020-12-31โ‚ฌ0.60 B40.84%
2019-12-31โ‚ฌ0.42 B837.86%
2018-12-31โ‚ฌ45.82 M47.05%
2017-12-31โ‚ฌ31.16 M-30.11%
2016-12-31โ‚ฌ44.59 M369.65%
2015-12-31โ‚ฌ9.49 M-7.36%
2014-12-31โ‚ฌ10.24 M124.36%
2013-12-31โ‚ฌ4.56 M-27.24%
2012-12-31โ‚ฌ6.27 M55.3%
2011-12-31โ‚ฌ4.04 M99.25%
2010-12-31โ‚ฌ2.02 M